:::

詳目顯示

回上一頁
題名:研究除外原則在專利法架構下之問題研究--以我國現階生物科技基礎研發之特質為例(下)
書刊名:智慧財產權月刊
作者:劉棠必
作者(外文):Liu, Tang-pi
出版日期:2003
卷期:56
頁次:頁16-50
主題關鍵詞:研究除外專利權排他權公共財准公共財生物科技交易成本產業政策
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(2) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:2
  • 共同引用共同引用:63
  • 點閱點閱:5
期刊論文
1.Eisenberg, Rebecca S.(1989)。Patents and the Progress of Science: Exclusive Rights and Experimental Use。The University of Chicago Law Review,56(3),1017-1086。  new window
2.Mueller, Janice M.(2001)。No "Dilettante Affair": Rethinking The Experimental Use Exception To Patent Infringement For Biomedical Research Tools。Washington Law Review,76(1),1-65。  new window
3.Watson, James D.、Crick, Francis. H. C.(1953)。Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid。Nature,171,737-738。  new window
4.Heller, Michael A.(1998)。The Tragedy of the Anticommons: Property in the Transition from Marx to Markets。Harvard Law Review,111(3),621-688。  new window
5.Attaran, Amir(2002)。The Doha Declaration on the TRIPS Agreement and Public Health, Access to Pharmaceuticals, and Options Under WTO Law。Fordham Intellectual Property, Media & Entertainment Law Journal,12,859-885。  new window
6.Parker, David L.(1994)。Patent Infringement Exemptions for Life Science Research。Houston Journal of International Law,16,615-663。  new window
7.Cohen, S.、Chang, A.、Boyer, H.、Helling, R.(1973)。Construction of Biologically Functional Bacterial Plasmids in Vitro。Proceedings of the National Academy of Sciences,70,3240-3244。  new window
8.劉秀真(19841200)。遺傳工程研究在我國之發展經過。科學發展月刊,12(12),1025-1031。  延伸查詢new window
9.Rai, Arti K.、Eisenberg, Rebecca S.(2003)。The Public Domain: Bayh-Dole Reform and the Progress of Biomedicine。Law and Contemporary Problems,66,289-314。  new window
10.孫智麗(2003)。我國生物科技人力供需現況分析。科技發展政策報導,3,188-196。  延伸查詢new window
11.Barash, Eyal H.(1997)。Experimental Uses, Patents, and Scientific Progress。Northwestern University Law Review,91,667-703。  new window
12.Milenkovich, Ned(1999)。Deleting the Bolar Amendment to the Hatch-Waxman Act: Harmonizing Pharmaceutical Patent Protection in a Global Village。The John Marshall Law Review,32,756-761。  new window
13.Bass, Naomi A.(2002)。Implications of the TRIPS Agreement for Developing Countries: Pharmaceutical Patent Laws in Brazil and South Africa in the 21st Century。George Washington International Law Review,34(1),197-199。  new window
14.Johnson, Jennifer J.(2003)。The experimental Use Exception in Japan: A Model for U.S. Patent law?。Pacific Rim Law & Policy Journal,12,501-502。  new window
15.Jones, Phillip B. C.(2002)。Navigating the Hatch-Waxman Act's Safe Harbor。Food and Drug Law Journal,57,475-487。  new window
16.Heller, Michael A.、Eisenberg, Rebecca S.(1998)。Can Patents Deter Innovation? The Anticommons in Biomedical Research。Science,280(1),698-701。  new window
17.Feisee, Lila(2002)。Current Plans and Visions for the Future the Role of the Private Sector in Biotechnology: Research and Development。Health Matrix,12,356-365。  new window
18.Marshall, Eliot(1997)。Battling Over Basics。Science,277,25。  new window
19.Avery, O. T.、MacLeod, C. M.、McCarty, M.(1944)。Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types。The Journal of Experimental Medicine,79,137-158。  new window
20.Hershey, A. D.、Chase, M.(1952)。Independent Function of Viral Protein and Nucleic Acid on Growth of Bacteriophage。The Journal of General Physiology,36,39-56。  new window
21.Linn, S.、Arber, W.(1968)。Host Specificity of DNA Produced by Escherichia coli, X: In Vitro Restriction of Phage fd Replicative Form。Proceedings of the National Academy of Sciences,59,1300-1306。  new window
22.Pate, Gregory N.(2002)。Analysis of the Experimental Use Exception。North Carolina Journal of Law & Technology,3(2),253。  new window
23.Karp, Jordan P.(1991)。Note: Experimental Use as Patent Infringement: The Impropriety of a Broad Exception。The Yale Law Journal,100,2169-2188。  new window
學位論文
1.林崇熙(1989)。台灣科技政策的歷史研究 (1949-1983年)(碩士論文)。國立清華大學。  延伸查詢new window
圖書
1.鄭中人(2002)。專利法逐條釋論。五南圖書出版股份有限公司。  延伸查詢new window
2.蔡明誠(2000)。發明專利法研究。臺北:臺灣大學法學叢書編輯委員會。new window  延伸查詢new window
3.Cooter, Robert、Ulen, Thomas(1997)。Law and Economics。Reading, Massachusetts:Addison-Wesley Educational Publishers Inc.。  new window
4.張清溪、許嘉棟、劉鶯釧、吳聰敏(1995)。經濟學--理論與實務。臺北:翰蘆圖書出版有限公司。  延伸查詢new window
5.Alberts, Bruce、Bray, Dennis、Lewis, Julian、Raff, Martin、Roberts, Keith、Watson, James D.(1994)。Molecular biology of the cell。Garland publishing, Inc.。  new window
6.Nicholson, Walter、李又剛(1996)。個體經濟學。臺北:華泰書局。  延伸查詢new window
7.Grubb, Philip W.(1999)。Patents for Chemicals, Pharmaceuticals and Biotechnology: Fundamentals of global law, Practice and Strategy。Oxford University Press。  new window
8.Ducor, Philippe G.(1998)。Patenting the Recombinant Products of Biotechnology and other Molecules。Kluwer Law International Ltd.。  new window
9.Burchfiel, Kenneth J.(1995)。Biotechnology and the Federal Circuit。The Bureau of National Affairs, Inc.。  new window
10.行政院國家科學委員會企畫考核處、財團法人經濟研究院(2002)。中華民國科學技術統計要覽。行政院國家科學委員會。  延伸查詢new window
11.陳哲宏、陳逸南、謝銘洋、徐宏昇(1997)。專利法解讀。元照出版公司。  延伸查詢new window
12.North, Douglass C.、劉瑞華(1995)。制度、制度變遷與經濟成就。時報文化出版企業股份有限公司。  延伸查詢new window
13.Neef, Dale、Siesfeld, G. Anthony、邸東輝、范建軍(2001)。知識對經濟的影響力。知書房出版社。  延伸查詢new window
14.Porter, Michael E.、李明軒、邱如美(1996)。國家競爭優勢。臺北:天下文化出版股份有限公司。  延伸查詢new window
15.Perelman, Michael(2002)。Steal this Idea: Intellectual Property Rights and the Corporate Confiscation of Creativity。New York:Palgrave。  new window
單篇論文
1.(20000317)。Canada: Patent Protection of Pharmaceutical Products: Complaint by the European Communities and their Member States爭端解決小組報告(WT/DS114/R)。  new window
其他
1.Organisation for Economic Co-operation and Development(1997)。National Innovation System,http://www.oecd.org/science/inno/2101733.pdf, 。  new window
2.智慧財產局。我國專利法規大事紀,http://www.tipo.gov.tw/public/Attachment/37914202575.pdf, 。  延伸查詢new window
3.OECD(2001)。The OECD Global Forums,http://webnet1.oecd.ora/pdf/M00040000/M00040936.pdf。  new window
4.行政院第二次科學技術會議,http://www.stic.gov.tw/stic/policy/scimeeting/a2-hd.htm。  延伸查詢new window
5.李秀眉,沈燕士,張正。生化科技產業(四)我國,http://linux.ttjhs.chc.edu.tw/-tea249/imaaes/carrvcd/ba2/ba2-17.htm。  延伸查詢new window
6.行政院科技顧問組。政策與法規--行政院生物技術產業策略(SRB)會議,http://biotek.nsc.aov.tw/2-01-01.html。  延伸查詢new window
7.江晃榮。臺灣地區生技產業發展政策與現況,http://www.bionet.org.tw/innovation/new19-4.html。  延伸查詢new window
8.孫智麗。知識經濟體系下創新政策的新思維--生技產業發展策略與政策意涵,http://home.kimo.com.tw/liutaho/b20.html。  延伸查詢new window
9.2002生技產業白皮書,http://www.biopharm.ora.tw/download/pdf/whitepage2002.pdf。  new window
10.張文(20030615)。我發現肝癌基因ARCAP九月上市驗血便能發現病變,http://news.chinatimes.com/Chinatimes/newslist/newslistcontent/0.3546.110501+112003061500011.0Q.html。  延伸查詢new window
11.Clark, Jeanne,Piccolo, Joe,Stanton, Brian,Tyson, Karin(2000)。Parent Pools: A Solution to the Problem of Access in Biotechnology Patents?,http://www.uspto.gov/web/offices/Dac/daDp/opla/patentpool.pdf。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關著作
 
無相關點閱
 
QR Code
QRCODE